ASCO 2023: Targeted Therapy for Early-Stage NSCLC
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
THE HEALTHBOOK COMPANY LTD.
2023-06-01
|
Series: | healthbook TIMES. Oncology Hematology |
Online Access: | https://doi.org/10.36000/hbT.OH.2023.16.113 |
_version_ | 1826936737028374528 |
---|---|
author | Roy Herbst |
author_facet | Roy Herbst |
author_sort | Roy Herbst |
collection | DOAJ |
first_indexed | 2024-03-08T10:20:01Z |
format | Article |
id | doaj.art-abda95a0f2574e589dcb00c6c7879bea |
institution | Directory Open Access Journal |
issn | 2673-2106 |
language | English |
last_indexed | 2025-02-17T18:26:44Z |
publishDate | 2023-06-01 |
publisher | THE HEALTHBOOK COMPANY LTD. |
record_format | Article |
series | healthbook TIMES. Oncology Hematology |
spelling | doaj.art-abda95a0f2574e589dcb00c6c7879bea2024-12-12T17:11:08ZengTHE HEALTHBOOK COMPANY LTD.healthbook TIMES. Oncology Hematology2673-21062023-06-01162ASCO 2023: Targeted Therapy for Early-Stage NSCLCRoy Herbsthttps://doi.org/10.36000/hbT.OH.2023.16.113 |
spellingShingle | Roy Herbst ASCO 2023: Targeted Therapy for Early-Stage NSCLC healthbook TIMES. Oncology Hematology |
title | ASCO 2023: Targeted Therapy for Early-Stage NSCLC |
title_full | ASCO 2023: Targeted Therapy for Early-Stage NSCLC |
title_fullStr | ASCO 2023: Targeted Therapy for Early-Stage NSCLC |
title_full_unstemmed | ASCO 2023: Targeted Therapy for Early-Stage NSCLC |
title_short | ASCO 2023: Targeted Therapy for Early-Stage NSCLC |
title_sort | asco 2023 targeted therapy for early stage nsclc |
url | https://doi.org/10.36000/hbT.OH.2023.16.113 |
work_keys_str_mv | AT royherbst asco2023targetedtherapyforearlystagensclc |